The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...